Abeona Therapeutics ABEO
NASDAQ ABEO
$4.40 -0.07 (-1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Long-Term Debt Repayments (2026)

Updated

Abeona Therapeutics' Long-Term Debt Repayments was $3.33 million in Q2 2026, up 50.0% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Long-Term Debt Repayments (2026) Analysis & Trends

For FY2012, Long-Term Debt Repayments at Abeona Therapeutics came in at $2.75 million, unchanged from FY2011.

  • In earlier years, Long-Term Debt Repayments was $2.75 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 1.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 2.00 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Abeona Therapeutics 251.79 Mn -462.16 Mn 7.20 Mn 3.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.33 Mn
Mar 31, 2026 2.22 Mn
API Access

Abeona Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABEO&period=max&api_key=YOUR_API_KEY